Loading IPO Details...
Upcoming IPOs
Healthcare Service Provider · Listed on BSE , NSE · 20 Feb 2026 - 24 Feb 2026
Jagat JoshiGaudium IVF, founded in March 2015, is one of the leading companies offering In Vitro Fertilization (IVF) treatments for women across India. The company operates its business over 30 locations, with seven hubs (centres) and twenty-eight spokes. The firm treats its patients in various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The firm offers various fertility services such as Vitro Fertilisation (IVF), intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction. Its treatments are targeted towards both genders. Moreover, the firm also provides PCOD/PCOS, endometriosis, and special care for women in pregnancy with complex fertility issues. Gaudium IVF also offers treatments targeting male infertility, including advanced sperm retrieval procedures.
| Date & Time | GMP (₹) | Est. Listing Price | Est. Gain (%) | Est. Profit / Lot (₹) |
|---|---|---|---|---|
| 27-Feb-2026 12:00 PM | ₹-4 | ₹75 | -5.06% | ₹-756 |
| 26-Feb-2026 12:00 PM | ₹-4 | ₹75 | -5.06% | ₹-756 |
| 25-Feb-2026 12:00 PM | +₹0 | ₹79 | +0.00% | ₹0 |
| 24-Feb-2026 12:00 PM | +₹5 | ₹84 | +6.33% | ₹945 |
| 23-Feb-2026 12:00 PM | +₹8.5 | ₹87.5 | +10.76% | ₹1,606.5 |
| 21-Feb-2026 12:00 PM | +₹8 | ₹87 | +10.13% | ₹1,512 |
| 20-Feb-2026 12:00 PM | +₹8 | ₹87 | +10.13% | ₹1,512 |
| 19-Feb-2026 12:00 PM | +₹10 | ₹89 | +12.66% | ₹1,890 |
| 18-Feb-2026 12:00 PM | +₹10 | ₹89 | +12.66% | ₹1,890 |
| 17-Feb-2026 12:00 PM | +₹10 | ₹89 | +12.66% | ₹1,890 |
| 16-Feb-2026 08:00 AM | +₹0 | ₹79 | +0.00% | ₹0 |
| 14-Feb-2026 08:00 AM | +₹0 | ₹79 | +0.00% | ₹0 |
| 13-Feb-2026 08:00 AM | +₹0 | ₹79 | +0.00% | ₹0 |
| Category | Subscription (x) | Shares Offered | Shares bid for | Total Amount (₹ Cr) |
|---|---|---|---|---|
| QIB (Ex. Anchor) | 1.62x | 41,77,240 | 67,85,478 | ₹53.61 Cr |
| NII | 14.05x | 31,32,930 | 4,40,22,069 | ₹347.77 Cr |
| bNII > ₹10L | 12.71x | 20,88,620 | 2,65,55,634 | ₹209.79 Cr |
| sNII < ₹10L | 16.73x | 10,44,310 | 1,74,66,435 | ₹137.98 Cr |
| Retail | 7.60x | 73,10,170 | 5,55,42,942 | ₹438.79 Cr |
| Total | 7.27x | 1,46,20,340 | 10,63,50,489 | ₹840.17 Cr |
| Period Ended | 30 SEPT 2025 | 31 MAR 2025 | 31 MAR 2024 |
|---|---|---|---|
| Total Income | 49.75 | 70.96 | 48.15 |
| Profit After Tax | 12.51 | 19.13 | 10.32 |
| EBITDA | 18.95 | 28.63 | 19.27 |
| NET Worth | 58.85 | 46.30 | 26.99 |
| Reserves and Surplus | 28.16 | 15.60 | 26.00 |
| Total Borrowing | 22.51 | 18.93 | 15.73 |
Peer comparison data will be updated soon.
Dr. Manika Khanna, Dr. Peeyush Khanna, Vishad Khanna are the company's promoters of Gaudium IVF & Women's Health Ltd.
| Particular | Pre IPO | Post IPO |
|---|---|---|
| Promoter and Promoter Group | 99.99% | 71.30% |
| Others* | 0.01% | 28.70% |
Join the discussion
Please sign in to leave a comment or reply.